SlideShare a Scribd company logo
1 of 21
HISTORY OF MEDICINE PROJECT
TOPIC- TREATMENT OF
A.I.D.S,WAYS
BY- ABHISHEK
GROUP NO-17
2nd semester,I.S.M
INTRODUCTION
 AIDS was first reported in 1981 and in last 25yrs or so it has spread all over the world,
 killing more than 25 million people. O It is an immunodeficiency disease caused by
 retrovirus called Human Immunodeficiency Virus which has RNA as its hereditary
 material. O High risk groups who become infected with this are homosexual men , bisexual men ,
male & female intravenous drug user.
SURVEY IN INDIAN CONTEXT
Main symptoms of AIDS
HIV
 HIV stands for human immunodeficiency virus. It
 is the virus that can lead to acquired immunodeficiency syndrome or AIDS if not
 treated. O Scientists identified a type of chimpanzee in
 Central Africa as the source of HIV infection in humans.
 They believe that the chimpanzee version of the immunodeficiency virus most likely was transmitted
to humans and mutated into HIV when humans hunted these chimpanzees for meat and came into
contact with their infected blood.
HIV GENOMIC STRUCTURE
H.I.V
Lentiviruses
Virus Diseases
Human Immunodeficiency Virus (HIV) Human AIDS
Simian Immunodeficiency Virus (SIV) AIDS in monkeys
Visna/maedi Virus Neurologic disease Virus
Stages of HIV
 Acute HIV Infection
 HIV Dormancy
Serological profile of HIV infection
Process Of HIV Infection
Diagnosis of HIV infection
 C4+ count
 Total leukocyte and lymphocyte count
 T-cell subsets assays
 Platelet count
 IgA and IgG levels
 Diminished cell mediated immunity
 Lymph node biopsy
 Isolation of antigens and antibodies
Elisa test
HARRT
 HARRT stands for Highly Active Anti
 Retroviral Therapy. It combines drugs from different classes
 slowing HIV replication down at different stages. Combinations are used for;
Blocking HIV replication by ART
Drugs involve HARRT
 Nucleoside reverse transcriptase inhibitors
 Non-nucleoside reverse transcriptase inhibitors
 Protease inhibitors
 Integrase inhibitor
 Fusion inhibitors
 Cytochrome P4503A inhibitors
 Chemokine co-receptor antagonist
Immune deficiency in HIV Infection
 Decreased cell mediated immune response
 Decreased activity of NK cells
 Decreased number of t helper cells
 Decreased activity of B lymphocytes
 Decreased activity of monocytes
 Macrophages
Immunotherapy for AIDS
 In this phenomenon transfusion based
 treatment is designed to replace lost immunoglobulins needed to fight HIV infection and it can be
done by;
Stem cell therapy for AIDS
 Researcher harvest HIV patients' own stem cells
 and attempt to genetically modify them so that they are able to block HIV from infecting CD4 T-cells.
 A donor who carries the mutation and is also a stem cell match for the patient is such a daunting
challenge.
 City of Hope's study seeks to find out if introducing a mimicked form of the CCR5 mutation will have
the same effect.
 The hope is that the mutated cells will survive, persist and replicate in the body, safely forming
protection against the HIV virus.

Conclusion
 AIDS is an immunodeficiency disease cause byHIV.
 HIV is highly mutable virus and exhibits frequent antigenic variations.
 HARRT is a life time therapy as it is only able to suppress HIV infection.
 Immunotherapy and stem cell therapy for AIDS is under research.
 No permanent cure for AIDS is present because of its high antigenic variations.

References
 Immunotherapy in HIV Infection, Division of Basic Science andVaccine Research, Institute of Human
Virology, University of Maryland School of Medicine, 2013 by Bhawna Pooniama
 HIV stem cell trials patient strives, Cycles for cure, 2017 | by Samantha Bona
 Human immunodeficiency virus and acquired immunodeficiency syndrome: an update by Schnittman
SM, Fauci AS
 Avani Sharma and Dr. Pushpa Maurya, 2011 |HIV with
 Special Reference to Antiretroviral Drugs- A thesis submitted to, Hemwati Nandan Bahuguna
Garhwal University (Uttarkhand)
 Kuby,Owen, Punt,Stranford (2013),AIDS and other Immunodeficiencies Immunology (431-461)
 Activate Windows O Sarita Aggarwal (2008), Human disease | Biology (683-695)
Deepankar aids

More Related Content

What's hot

Study finds some people less susceptible to H7N9 influenza virus than others
Study finds some people less susceptible to H7N9 influenza virus than othersStudy finds some people less susceptible to H7N9 influenza virus than others
Study finds some people less susceptible to H7N9 influenza virus than othersHarm Kiezebrink
 
Yolken webinar
Yolken webinarYolken webinar
Yolken webinarwef
 
Hepatitisevirusinfection 170128064911
Hepatitisevirusinfection 170128064911Hepatitisevirusinfection 170128064911
Hepatitisevirusinfection 170128064911Oluwafemi Oladipupo
 
Some quick facts and numbers on Coronavirus (COVID-19)
Some quick facts and numbers on Coronavirus (COVID-19) Some quick facts and numbers on Coronavirus (COVID-19)
Some quick facts and numbers on Coronavirus (COVID-19) Slide Marvels
 
Hiv classics11252013
Hiv classics11252013Hiv classics11252013
Hiv classics11252013pkhohl
 
Diabetes milletes immunopathaogenesis
Diabetes milletes immunopathaogenesisDiabetes milletes immunopathaogenesis
Diabetes milletes immunopathaogenesisAbdelrahman Al-daqqa
 
Biology 9 th ch-2 - long q
Biology  9 th ch-2 - long qBiology  9 th ch-2 - long q
Biology 9 th ch-2 - long qImtiaz Hussain
 
Transplantation Immunity. Antitumor Immunity. Autoimmune Diseases
Transplantation Immunity. Antitumor Immunity. Autoimmune DiseasesTransplantation Immunity. Antitumor Immunity. Autoimmune Diseases
Transplantation Immunity. Antitumor Immunity. Autoimmune DiseasesEneutron
 
2,000 proteins present in hiv virus
2,000 proteins present in hiv virus2,000 proteins present in hiv virus
2,000 proteins present in hiv virusrita martin
 

What's hot (20)

Study finds some people less susceptible to H7N9 influenza virus than others
Study finds some people less susceptible to H7N9 influenza virus than othersStudy finds some people less susceptible to H7N9 influenza virus than others
Study finds some people less susceptible to H7N9 influenza virus than others
 
Yolken webinar
Yolken webinarYolken webinar
Yolken webinar
 
Covid 19
Covid 19Covid 19
Covid 19
 
Hepatitisevirusinfection 170128064911
Hepatitisevirusinfection 170128064911Hepatitisevirusinfection 170128064911
Hepatitisevirusinfection 170128064911
 
Duesberg Assignment
Duesberg AssignmentDuesberg Assignment
Duesberg Assignment
 
Some quick facts and numbers on Coronavirus (COVID-19)
Some quick facts and numbers on Coronavirus (COVID-19) Some quick facts and numbers on Coronavirus (COVID-19)
Some quick facts and numbers on Coronavirus (COVID-19)
 
Hiv classics11252013
Hiv classics11252013Hiv classics11252013
Hiv classics11252013
 
Bronchial Challenge Testing
Bronchial Challenge TestingBronchial Challenge Testing
Bronchial Challenge Testing
 
Diabetes milletes immunopathaogenesis
Diabetes milletes immunopathaogenesisDiabetes milletes immunopathaogenesis
Diabetes milletes immunopathaogenesis
 
Carvalho 2008
Carvalho 2008Carvalho 2008
Carvalho 2008
 
Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dysplasia
Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal DysplasiaAutoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dysplasia
Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dysplasia
 
Biology 9 th ch-2 - long q
Biology  9 th ch-2 - long qBiology  9 th ch-2 - long q
Biology 9 th ch-2 - long q
 
IJBAMR Case report-Leptospirosis
IJBAMR Case report-LeptospirosisIJBAMR Case report-Leptospirosis
IJBAMR Case report-Leptospirosis
 
Hiv vrus
Hiv vrus Hiv vrus
Hiv vrus
 
Hiv aids
Hiv aidsHiv aids
Hiv aids
 
HIV / AIDS Pathology
HIV / AIDS PathologyHIV / AIDS Pathology
HIV / AIDS Pathology
 
PLASMA THERAPY
PLASMA THERAPYPLASMA THERAPY
PLASMA THERAPY
 
Transplantation Immunity. Antitumor Immunity. Autoimmune Diseases
Transplantation Immunity. Antitumor Immunity. Autoimmune DiseasesTransplantation Immunity. Antitumor Immunity. Autoimmune Diseases
Transplantation Immunity. Antitumor Immunity. Autoimmune Diseases
 
2,000 proteins present in hiv virus
2,000 proteins present in hiv virus2,000 proteins present in hiv virus
2,000 proteins present in hiv virus
 
News2
News2News2
News2
 

Similar to Deepankar aids

HIV UPDATE TREATMENT
HIV UPDATE TREATMENTHIV UPDATE TREATMENT
HIV UPDATE TREATMENTrafa64
 
Journal Reading Stem Cell dengan HIV (sharon)
Journal Reading Stem Cell dengan HIV (sharon) Journal Reading Stem Cell dengan HIV (sharon)
Journal Reading Stem Cell dengan HIV (sharon) soroylardo1
 
Management of patient with AIDS
Management of patient with AIDSManagement of patient with AIDS
Management of patient with AIDSMathew Varghese V
 
13-HIV & AIDS.Hope 25.03.22.pptx
13-HIV & AIDS.Hope 25.03.22.pptx13-HIV & AIDS.Hope 25.03.22.pptx
13-HIV & AIDS.Hope 25.03.22.pptxTysonPhiri
 
Immunology and Detection of Acute HIV-1 Infection
Immunology and Detection of Acute HIV-1 InfectionImmunology and Detection of Acute HIV-1 Infection
Immunology and Detection of Acute HIV-1 InfectionRongpong Plongla
 
Microbiology hiv-yf
Microbiology   hiv-yfMicrobiology   hiv-yf
Microbiology hiv-yfMBBS IMS MSU
 
Anti-HIV standard regimens and newer drugs
Anti-HIV standard regimens and newer drugsAnti-HIV standard regimens and newer drugs
Anti-HIV standard regimens and newer drugsShivanshu Bajaj
 
HIV & AIDS- RAHUL SAHU
HIV & AIDS- RAHUL SAHUHIV & AIDS- RAHUL SAHU
HIV & AIDS- RAHUL SAHURahul Sahu
 
Immune Based Therapies for HIV Richard Trauger, phd
Immune Based Therapies for HIV Richard Trauger, phdImmune Based Therapies for HIV Richard Trauger, phd
Immune Based Therapies for HIV Richard Trauger, phdSearch For A Cure
 
Marios_Stylianou_PhD thesis
Marios_Stylianou_PhD thesisMarios_Stylianou_PhD thesis
Marios_Stylianou_PhD thesisMarios Stylianou
 
Hiv(human immunodeficiency virus)
Hiv(human immunodeficiency virus)Hiv(human immunodeficiency virus)
Hiv(human immunodeficiency virus)Ademola Dada
 

Similar to Deepankar aids (20)

HIV UPDATE TREATMENT
HIV UPDATE TREATMENTHIV UPDATE TREATMENT
HIV UPDATE TREATMENT
 
Journal Reading Stem Cell dengan HIV (sharon)
Journal Reading Stem Cell dengan HIV (sharon) Journal Reading Stem Cell dengan HIV (sharon)
Journal Reading Stem Cell dengan HIV (sharon)
 
AIDS
AIDSAIDS
AIDS
 
HIV
HIVHIV
HIV
 
Management of patient with AIDS
Management of patient with AIDSManagement of patient with AIDS
Management of patient with AIDS
 
AIDS and HEPATITIS
AIDS and HEPATITIS  AIDS and HEPATITIS
AIDS and HEPATITIS
 
13-HIV & AIDS.Hope 25.03.22.pptx
13-HIV & AIDS.Hope 25.03.22.pptx13-HIV & AIDS.Hope 25.03.22.pptx
13-HIV & AIDS.Hope 25.03.22.pptx
 
Hiv
HivHiv
Hiv
 
Hivaids, racing to the finish point
Hivaids, racing to the finish pointHivaids, racing to the finish point
Hivaids, racing to the finish point
 
Immunology and Detection of Acute HIV-1 Infection
Immunology and Detection of Acute HIV-1 InfectionImmunology and Detection of Acute HIV-1 Infection
Immunology and Detection of Acute HIV-1 Infection
 
Microbiology hiv-yf
Microbiology   hiv-yfMicrobiology   hiv-yf
Microbiology hiv-yf
 
Anti-HIV standard regimens and newer drugs
Anti-HIV standard regimens and newer drugsAnti-HIV standard regimens and newer drugs
Anti-HIV standard regimens and newer drugs
 
Hiv
HivHiv
Hiv
 
Hiv infection by ved
Hiv infection by vedHiv infection by ved
Hiv infection by ved
 
HIV & AIDS- RAHUL SAHU
HIV & AIDS- RAHUL SAHUHIV & AIDS- RAHUL SAHU
HIV & AIDS- RAHUL SAHU
 
Hiv and surgeon.pptx shivraj
Hiv and surgeon.pptx shivrajHiv and surgeon.pptx shivraj
Hiv and surgeon.pptx shivraj
 
Immune Based Therapies for HIV Richard Trauger, phd
Immune Based Therapies for HIV Richard Trauger, phdImmune Based Therapies for HIV Richard Trauger, phd
Immune Based Therapies for HIV Richard Trauger, phd
 
Marios_Stylianou_PhD thesis
Marios_Stylianou_PhD thesisMarios_Stylianou_PhD thesis
Marios_Stylianou_PhD thesis
 
Hiv(human immunodeficiency virus)
Hiv(human immunodeficiency virus)Hiv(human immunodeficiency virus)
Hiv(human immunodeficiency virus)
 
Hiv infection
Hiv infection Hiv infection
Hiv infection
 

More from ABHISHEK

Cells of the immune system
Cells of the immune systemCells of the immune system
Cells of the immune systemABHISHEK
 
First line of defense ( barrier mechanisms)
First line of defense ( barrier mechanisms)First line of defense ( barrier mechanisms)
First line of defense ( barrier mechanisms)ABHISHEK
 
Second line of defense
Second line of defenseSecond line of defense
Second line of defenseABHISHEK
 
Vaccination
Vaccination Vaccination
Vaccination ABHISHEK
 
Tuberculosis. epidemiology person, place, time graph
Tuberculosis. epidemiology person, place, time graphTuberculosis. epidemiology person, place, time graph
Tuberculosis. epidemiology person, place, time graphABHISHEK
 
Trauma epidemiology person, place, time graph
Trauma epidemiology person, place, time graphTrauma epidemiology person, place, time graph
Trauma epidemiology person, place, time graphABHISHEK
 
Stroke epidemiology person, place, time graph
Stroke epidemiology person, place, time graphStroke epidemiology person, place, time graph
Stroke epidemiology person, place, time graphABHISHEK
 
Sexually transmitted diseases (st ds) epidemiology person, place, time graph
Sexually transmitted diseases (st ds) epidemiology person, place, time graphSexually transmitted diseases (st ds) epidemiology person, place, time graph
Sexually transmitted diseases (st ds) epidemiology person, place, time graphABHISHEK
 
Pneumonia.epidemiology person, place, time graph
Pneumonia.epidemiology  person, place, time graphPneumonia.epidemiology  person, place, time graph
Pneumonia.epidemiology person, place, time graphABHISHEK
 
Malaria disease epidemiology person, place, time graph
Malaria disease epidemiology person, place, time graphMalaria disease epidemiology person, place, time graph
Malaria disease epidemiology person, place, time graphABHISHEK
 
Hypertension.epidemiology person, place, time graph
Hypertension.epidemiology person, place, time graphHypertension.epidemiology person, place, time graph
Hypertension.epidemiology person, place, time graphABHISHEK
 
Hiv disease epidemiology person, place, time graph
Hiv disease epidemiology person, place, time graphHiv disease epidemiology person, place, time graph
Hiv disease epidemiology person, place, time graphABHISHEK
 
Hepatitis epidemiology person, place, time graph
Hepatitis epidemiology person, place, time graphHepatitis epidemiology person, place, time graph
Hepatitis epidemiology person, place, time graphABHISHEK
 
Hepatitis – b ,epidemiology person, place, time graph
Hepatitis – b ,epidemiology person, place, time graphHepatitis – b ,epidemiology person, place, time graph
Hepatitis – b ,epidemiology person, place, time graphABHISHEK
 
Diabetes epidemiology person, place, time graph
Diabetes epidemiology person, place, time graphDiabetes epidemiology person, place, time graph
Diabetes epidemiology person, place, time graphABHISHEK
 
Covid 19 epidemiology
Covid 19 epidemiologyCovid 19 epidemiology
Covid 19 epidemiologyABHISHEK
 
Botulism I.S.M CENTRAL CAMPUS
Botulism I.S.M CENTRAL CAMPUSBotulism I.S.M CENTRAL CAMPUS
Botulism I.S.M CENTRAL CAMPUSABHISHEK
 
Helminthi I.S.M CENTRAL CAMPUS
Helminthi I.S.M CENTRAL CAMPUSHelminthi I.S.M CENTRAL CAMPUS
Helminthi I.S.M CENTRAL CAMPUSABHISHEK
 
Hepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUSHepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUSABHISHEK
 
Human immuno defeciency I.S.M CENTRAL CAMPUS
Human immuno defeciency  I.S.M CENTRAL CAMPUSHuman immuno defeciency  I.S.M CENTRAL CAMPUS
Human immuno defeciency I.S.M CENTRAL CAMPUSABHISHEK
 

More from ABHISHEK (20)

Cells of the immune system
Cells of the immune systemCells of the immune system
Cells of the immune system
 
First line of defense ( barrier mechanisms)
First line of defense ( barrier mechanisms)First line of defense ( barrier mechanisms)
First line of defense ( barrier mechanisms)
 
Second line of defense
Second line of defenseSecond line of defense
Second line of defense
 
Vaccination
Vaccination Vaccination
Vaccination
 
Tuberculosis. epidemiology person, place, time graph
Tuberculosis. epidemiology person, place, time graphTuberculosis. epidemiology person, place, time graph
Tuberculosis. epidemiology person, place, time graph
 
Trauma epidemiology person, place, time graph
Trauma epidemiology person, place, time graphTrauma epidemiology person, place, time graph
Trauma epidemiology person, place, time graph
 
Stroke epidemiology person, place, time graph
Stroke epidemiology person, place, time graphStroke epidemiology person, place, time graph
Stroke epidemiology person, place, time graph
 
Sexually transmitted diseases (st ds) epidemiology person, place, time graph
Sexually transmitted diseases (st ds) epidemiology person, place, time graphSexually transmitted diseases (st ds) epidemiology person, place, time graph
Sexually transmitted diseases (st ds) epidemiology person, place, time graph
 
Pneumonia.epidemiology person, place, time graph
Pneumonia.epidemiology  person, place, time graphPneumonia.epidemiology  person, place, time graph
Pneumonia.epidemiology person, place, time graph
 
Malaria disease epidemiology person, place, time graph
Malaria disease epidemiology person, place, time graphMalaria disease epidemiology person, place, time graph
Malaria disease epidemiology person, place, time graph
 
Hypertension.epidemiology person, place, time graph
Hypertension.epidemiology person, place, time graphHypertension.epidemiology person, place, time graph
Hypertension.epidemiology person, place, time graph
 
Hiv disease epidemiology person, place, time graph
Hiv disease epidemiology person, place, time graphHiv disease epidemiology person, place, time graph
Hiv disease epidemiology person, place, time graph
 
Hepatitis epidemiology person, place, time graph
Hepatitis epidemiology person, place, time graphHepatitis epidemiology person, place, time graph
Hepatitis epidemiology person, place, time graph
 
Hepatitis – b ,epidemiology person, place, time graph
Hepatitis – b ,epidemiology person, place, time graphHepatitis – b ,epidemiology person, place, time graph
Hepatitis – b ,epidemiology person, place, time graph
 
Diabetes epidemiology person, place, time graph
Diabetes epidemiology person, place, time graphDiabetes epidemiology person, place, time graph
Diabetes epidemiology person, place, time graph
 
Covid 19 epidemiology
Covid 19 epidemiologyCovid 19 epidemiology
Covid 19 epidemiology
 
Botulism I.S.M CENTRAL CAMPUS
Botulism I.S.M CENTRAL CAMPUSBotulism I.S.M CENTRAL CAMPUS
Botulism I.S.M CENTRAL CAMPUS
 
Helminthi I.S.M CENTRAL CAMPUS
Helminthi I.S.M CENTRAL CAMPUSHelminthi I.S.M CENTRAL CAMPUS
Helminthi I.S.M CENTRAL CAMPUS
 
Hepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUSHepatitis I.S.M CENTRAL CAMPUS
Hepatitis I.S.M CENTRAL CAMPUS
 
Human immuno defeciency I.S.M CENTRAL CAMPUS
Human immuno defeciency  I.S.M CENTRAL CAMPUSHuman immuno defeciency  I.S.M CENTRAL CAMPUS
Human immuno defeciency I.S.M CENTRAL CAMPUS
 

Recently uploaded

Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 

Recently uploaded (20)

Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 

Deepankar aids

  • 1. HISTORY OF MEDICINE PROJECT TOPIC- TREATMENT OF A.I.D.S,WAYS BY- ABHISHEK GROUP NO-17 2nd semester,I.S.M
  • 2. INTRODUCTION  AIDS was first reported in 1981 and in last 25yrs or so it has spread all over the world,  killing more than 25 million people. O It is an immunodeficiency disease caused by  retrovirus called Human Immunodeficiency Virus which has RNA as its hereditary  material. O High risk groups who become infected with this are homosexual men , bisexual men , male & female intravenous drug user.
  • 5. HIV  HIV stands for human immunodeficiency virus. It  is the virus that can lead to acquired immunodeficiency syndrome or AIDS if not  treated. O Scientists identified a type of chimpanzee in  Central Africa as the source of HIV infection in humans.  They believe that the chimpanzee version of the immunodeficiency virus most likely was transmitted to humans and mutated into HIV when humans hunted these chimpanzees for meat and came into contact with their infected blood.
  • 7. Lentiviruses Virus Diseases Human Immunodeficiency Virus (HIV) Human AIDS Simian Immunodeficiency Virus (SIV) AIDS in monkeys Visna/maedi Virus Neurologic disease Virus
  • 8. Stages of HIV  Acute HIV Infection  HIV Dormancy
  • 9. Serological profile of HIV infection
  • 10. Process Of HIV Infection
  • 11. Diagnosis of HIV infection  C4+ count  Total leukocyte and lymphocyte count  T-cell subsets assays  Platelet count  IgA and IgG levels  Diminished cell mediated immunity  Lymph node biopsy  Isolation of antigens and antibodies
  • 13. HARRT  HARRT stands for Highly Active Anti  Retroviral Therapy. It combines drugs from different classes  slowing HIV replication down at different stages. Combinations are used for;
  • 15. Drugs involve HARRT  Nucleoside reverse transcriptase inhibitors  Non-nucleoside reverse transcriptase inhibitors  Protease inhibitors  Integrase inhibitor  Fusion inhibitors  Cytochrome P4503A inhibitors  Chemokine co-receptor antagonist
  • 16. Immune deficiency in HIV Infection  Decreased cell mediated immune response  Decreased activity of NK cells  Decreased number of t helper cells  Decreased activity of B lymphocytes  Decreased activity of monocytes  Macrophages
  • 17. Immunotherapy for AIDS  In this phenomenon transfusion based  treatment is designed to replace lost immunoglobulins needed to fight HIV infection and it can be done by;
  • 18. Stem cell therapy for AIDS  Researcher harvest HIV patients' own stem cells  and attempt to genetically modify them so that they are able to block HIV from infecting CD4 T-cells.  A donor who carries the mutation and is also a stem cell match for the patient is such a daunting challenge.  City of Hope's study seeks to find out if introducing a mimicked form of the CCR5 mutation will have the same effect.  The hope is that the mutated cells will survive, persist and replicate in the body, safely forming protection against the HIV virus. 
  • 19. Conclusion  AIDS is an immunodeficiency disease cause byHIV.  HIV is highly mutable virus and exhibits frequent antigenic variations.  HARRT is a life time therapy as it is only able to suppress HIV infection.  Immunotherapy and stem cell therapy for AIDS is under research.  No permanent cure for AIDS is present because of its high antigenic variations. 
  • 20. References  Immunotherapy in HIV Infection, Division of Basic Science andVaccine Research, Institute of Human Virology, University of Maryland School of Medicine, 2013 by Bhawna Pooniama  HIV stem cell trials patient strives, Cycles for cure, 2017 | by Samantha Bona  Human immunodeficiency virus and acquired immunodeficiency syndrome: an update by Schnittman SM, Fauci AS  Avani Sharma and Dr. Pushpa Maurya, 2011 |HIV with  Special Reference to Antiretroviral Drugs- A thesis submitted to, Hemwati Nandan Bahuguna Garhwal University (Uttarkhand)  Kuby,Owen, Punt,Stranford (2013),AIDS and other Immunodeficiencies Immunology (431-461)  Activate Windows O Sarita Aggarwal (2008), Human disease | Biology (683-695)

Editor's Notes

  1. NOTE: To change the image on this slide, select the picture and delete it. Then click the Pictures icon in the placeholder to insert your own image.